Modulation of Phase II Drug Metabolizing Enzyme Activities by N-Heterocycles

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|3|6|599-607

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.3, Iss.6, 2002-01, pp. : 599-607

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer and Phase II Drug-Metabolizing Enzymes

By  

Current Drug Metabolism, Vol. 4, Iss. 1, 2003-02 ,pp. : 45-58

Bentham Science Publishers

Access to resources Recommend Favorite

Human Arylamine N-Acetyltransferase 1: A Drug-Metabolizing Enzyme and a Drug Target?

By  

Current Drug Targets, Vol. 11, Iss. 6, 2010-06 ,pp. : 759-766

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics, Regulation and Signaling Pathways of Phase I and II Drug Metabolizing Enzymes

By  

Current Drug Metabolism, Vol. 3, Iss. 5, 2002-10 ,pp. : 481-490

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Phase II Drug Metabolizing Enzymes in Cancer Chemoprevention

By  

Current Drug Metabolism, Vol. 10, Iss. 6, 2009-07 ,pp. : 595-616

Bentham Science Publishers

Access to resources Recommend Favorite

Relevance of Drug Metabolizing Enzyme Activity Modulation by Tea Polyphenols in the Inhibition of Esophageal Tumorigenesis

By  

Medicinal Chemistry, Vol. 7, Iss. 5, 2011-09 ,pp. : 480-487

Bentham Science Publishers

Access to resources Recommend Favorite